Vimarsana
Biggest News Aggregation in the World

Page 2 - Current Problems News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Current Problems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Current Problems Today - Breaking & Trending Today

Fact Check: Hamas.com Is a Website for Hamas? - Vimarsana News

Fact Check: Hamas.com Is a Website for Hamas?

Forensic evidence indicated the website was created on an Israeli platform.

Source: yahoo.com
Phil Neel with Komite - Vimarsana News

Phil Neel with Komite

The following interview was conducted by Komite in English and subsequently translated into Turkish, to be published on their web platform in two parts.1 Komite is a Turkish collective of socialist militants who call for a break with the corrupt and inefficient institutions of the existing Turkish labor movement, mobilizing class politics to militate against the sweatshop regime of neoliberal globalization and the political oppression conducted by the current government.

Sacubitril/Valsartan Reduces Natriuretic Peptide Levels, Improves QOL in Patients With HFpEF - Vimarsana News

Sacubitril/Valsartan Reduces Natriuretic Peptide Levels, Improves QOL in Patients With HFpEF

The improvement in quality of life (QOL) seen with use of sacubitril/valsartan for heart failure with preserved ejection fraction (HFpEF) could potentially result in more favorable clinical results.

Source: ajmc.com
Vaping vs. Smoking: Is One Really Safer Than the Other? - Vimarsana News

Vaping vs. Smoking: Is One Really Safer Than the Other?

Vaping has emerged as an increasingly popular alternative to smoking.

Bempedoic Acid's Benefits, Risks for Patients at High Cardiovascular Risk - Vimarsana News

Bempedoic Acid's Benefits, Risks for Patients at High Cardiovascular Risk

Compared with placebo, bempedoic acid therapy decreased the risk for major adverse cardiovascular events among patients at high cardiovascular risk, according to a new systematic review and meta-analysis. Bempedoic acid is approved for heterozygous familial hypercholesterolemia and atherosclerotic cardiovascular disease.

Source: empr.com